Hsbc Holdings PLC Sage Therapeutics, Inc. Transaction History

Hsbc Holdings PLC

$159 Billion
Q1 2025

A detailed history of Hsbc Holdings PLC transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Hsbc Holdings PLC holds 10,977 shares of SAGE stock, worth $71,679. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,977

Holding current value

$71,679

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2025 May 14, 2025	BUY	$5.55 - $8.66 $60,922 - $95,060	10,977 New	10,977 $87,000
Q1 2024 May 15, 2024	BUY	$18.62 - $26.95 $1.56 Million - $2.25 Million	83,577 New	83,577 $1.57 Million

Others Institutions Holding SAGE

# of Institutions

217

Shares Held

49.9M

Call Options Held

220K

Put Options Held

312K

Black Rock Inc. New York, NY

5.22M
Shares

$34.1 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

5.08M
Shares

$33.2 Million
0.0% of portfolio
Madison Avenue Partners, LP New York, NY

4.48M
Shares

$29.2 Million
4.6% of portfolio
Tig Advisors, LLC New York, NY

2.73M
Shares

$17.8 Million
1.36% of portfolio
D. E. Shaw & Co., Inc. New York, NY

2.09M
Shares

$13.6 Million
0.02% of portfolio

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $388M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Account